Delivery Order SPE2DB25D3020-SPE2DB25FWJPH
- Not listed
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a $2,140.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside contract was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,702.82 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle extending through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,186.45 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion required by July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,884.30 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injectors (two-pack) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency Troop Support Medical awarded a $1,794.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561438046 epinephrine autoinjectors (0.3 mg, 2-pack). Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 7-10, 2023. The award was made under an existing DLA medical supply vehicle, though details of the master agreement were not provided. As the nation's largest...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-inject 2-packs, with a ceiling value of $1,131.06 under a firm fixed-price contract type. Awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, this delivery order represents a non-set-aside, competitively awarded procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $31,368.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of epinephrine auto-injectors. The contract calls for Amerisourcebergen to deliver 4562032156 units of 0.3 mg epinephrine auto-injectors to a location in Conshohocken, Pennsylvania by September 5, 2023 to support DLA's medical supply needs. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will leverage its extensive distribution...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,592.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,727,625 units of Epinephrine 0.3 mg auto-injector 2-packs. The contract has a firm fixed price and an ultimate completion date of December 17, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), is the prime contractor with no set-aside designation...
- The Defense Logistics Agency awarded a $15,558.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for epinephrine auto-injectors. As the prime contractor, Amerisourcebergen will deliver 4562070945 units of 0.3 mg epinephrine auto-injectors to a location in Conshohocken, Pennsylvania by September 7, 2023 to support Defense Logistics Agency requirements. The delivery order was awarded under an existing Amerisourcebergen contract vehicle but no further contract details were...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWJPHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,387.28 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires completion by July 21, 2025. The order was issued on July 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The auto-injector delivery supports critical emergency medical needs across the Defense Health Agency and other government healthcare systems operating under DLA's Pharmaceutical Prime Vendor program structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/18/25 |